GOAL
The purpose of the 3rd Annual Johns Hopkins Dystonia &
Spasticity Practicum will be to educate residents and fellows
on the science and clinical issues related to the management
of dystonia and spasticity. This educational activity seeks to
provide residents and fellows with in-depth, evidence-based
education that includes hands-on experience in treating
patients with dystonia and spasticity.
Return to Top
INTENDED AUDIENCE
This activity is designed for residents and fellows in the fields of
neurology and physical medicine and rehabilitation. No prerequisites
required.
Return to Top
AGENDA
8:30 – 9:00 AM
Registration and Breakfast
9:00 – 9:25 AM
Introduction and Educational Outcomes Activity
9:25 – 10:10 AM
Dystonia: Introduction and Overview
10:10 – 10:20 AM
Question and Answer Session
10:20 – 11:05 AM
Spasticity: Introduction and Overview
11:05 – 11:15 AM
Question and Answer Session
11:15 – 11:20 AM
Break
11:20 – 12:05 PM
Chemodenervation: Basics and Practical Considerations
12:05 – 12:15 PM
Question and Answer Session
12:15 – 1:00 PM
Lunch: Reflection/Discussion
1:00 – 3:00 PM
Breakout Sessions: Injection Training Workshops
A. Models (ELVIS/ELVIRA)
B. Spasticity (Live Patients)
C. Dystonia (Live Patients)
3:00 – 3:20 PM
Educational Outcomes Activity
3:20 – 3:30 PM
Conclusion/Adjourn
Return to Top
ADVISORY BOARD
Cynthia L. Comella, MD
Professor
Department of Neurological Sciences
Movement Disorders Section
Rush University Medical Center
Chicago, IL
Zoltan Mari, MD
Assistant Professor
Department of Neurology
The Johns Hopkins University School of Medicine
Baltimore, MD
Daniel Tarsy, MD
Professor
Department of Neurology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA
R. Samuel Mayer, MD
Assistant Professor
Vice Chair, Education
Residency Program Director
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Medical Director-Inpatient Rehabilitation and Physician Advisor
Department of Physical Medicine and Rehabilitation
Johns Hopkins Hospital
Faculty
Allison Brashear, MD
Professor and Chair
Department of Neurology
Wake Forest University School of Medicine
Winston-Salem, NC
Amy Colcher, MD
Clinical Associate Professor of Neurology
Department of Neurology
University of Pennsylvania Health System
Philadelphia, PA
Paul Greene, MD
Associate Professor of Neurology
Department of Neurology
Columbia University Medical Center
New York, NY
Joseph Jankovic, MD
Professor of Neurology
Distinguished Chair in Movement Disorders
Director, Parkinson’s Disease Center and Movement Disorders Clinic
Co-Director, Parkinson’s Disease Research Laboratory
Baylor College of Medicine
Department of Neurology
Houston, TX
Barbara I. Karp, MD
Chair
Combined NeuroScience and National Institute on Drug Abuse Institutional Review Boards
National Institutes of Health
Katie Kompoliti, MD
Associate Professor of Neurological Sciences
Rush University Medical Center
Fatta B. Nahab, MD
Assistant Professor of Neurology
Miller School of Medicine
University of Miami
Miami, FL
Jill Ostrem, MD
Neurologist, Department of Neurology
Associate Professor of Neurology
University of California, San Francisco Medical Center
San Francisco, CA
Nutan Sharma, MD PhD
Assistant Professor of Neurology
Massachusetts General Hospital
Associate Neurologist
Brigham and Women's Hospital
Assistant Professor of Neurology
Harvard Medical School
Return to Top
LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:
- EVALUATE patients with dystonia or spasticity and
compare/contrast available evidenced-based treatments.
- DESCRIBE the clinically relevant distinctions between botulinum toxins A and B by a review of clinical trial data, and identify those patients most appropriately
treated with each toxin.
- DEMONSTRATE proficiency in the administration of chemodenervation
treatment for spasticity and dystonia.
The Johns Hopkins University School of Medicine takes
responsibility for the content, quality, and scientific integrity
of this CME activity.
Return to Top
CME INFORMATION
Accreditation Statement — The Johns Hopkins University
School of Medicine is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical
education for physicians.
Credit Designation Statement — The Johns Hopkins
University School of Medicine designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure — It is the
policy of The Johns Hopkins University School of Medicine that
the faculty and provider disclose real or apparent conflicts of
interest relating to the topics of this educational activity, and
also disclose discussions of unlabeled/unapproved uses of
drugs or devices during their presentation(s). The Johns
Hopkins University School of Medicine OCME has established
policies in place that will identify and resolve all conflicts of
interest prior to this educational activity. Detailed disclosures
will be made in the course handout materials.
Americans with Disabilities Act (ADA) — The Johns
Hopkins University School of Medicine fully complies with
the legal requirements of the ADA and the rules and regulations
thereof. Please notify us if you have any special
needs.
Fee Information — There is no fee for this educational activity
Return to Top
|